Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
Cackowski v. Wal-Mart Stores, Inc. (2000)
Camara v. Municipal Court (1967)
Candidate for Certified Pharmacy Technician
causation, malpractice
See change being effected (CBE) supplement Drug Price Competition and Patent Term Restoration Act of 1984 See change being effected (CBE) supplement Whether FDA-Approved Labeling Preempts State Product Liability Actions New Drug Approval The Road to an Approved New Drug Application
Center for Devices and Radiological Health, FDA
Centers for Medicare and Medicaid Services (CMS) Background laws made by
Centocor, Inc. v. Hamilton et al. (2012)
Central Hudson Gas v. Public Service Commission (1980)
Certificate of Registration revocation of - Daniel Family Pharmacy application for
See current good manufacturing practices (CGMP) Adulteration Current Good Manufacturing Practice Dietary Supplements vs Drugs Drug Quality and Security Act of 2013 Medical Devices See current good manufacturing practices (CGMP) Cosmetics Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics Drug Quality and Security Act of 2013 FDAMA's Compounding Provisions (§ 503A): Later Reinstated as § 503A Under the DQSA Pharmacy Compounding vs Manufacturing
Cafazzo v. Central Medical Health Services, Inc. (1995)
Canadian pharmacies
case citation and analysis
Cazes v. Raisinger (1983)
Center for Biologics Evaluation and Research, FDA
Center for Drug Evaluation and Research (CDER), FDA
central fill pharmacy
certification requirements, electronic transmission prescriptions
change being effected (CBE) supplement The Road to an Approved New Drug Application Whether FDA-Approved Labeling Preempts State Product Liability Actions
Chemical Diversion and Trafficking Act (1988)
Cholestin
civil court procedures
Civil Rights Act of 1964
claims false advertising food health claims Dietary Supplement Health and Education Act 1994 False Claims Act health/disease
classification system Schedule I (Drugs and Other Substances) schedule II drugs schedule IV drugs schedule I drugs schedule III drugs schedule V drugs
clinical judgment exercises
clinical trials informed consent Investigational New Drug (IND) application application for registration investigational drugs, access to registration requirements
Clozaril Patient Management System
See consumer medication information (CMI) Prescription Drug Labeling Information for the Patient Useful Written Patient Information and Medication Guides Approved Drugs for Off-Label (Unlabeled) Indications See consumer medication information (CMI)